MILLENNIUM MANAGEMENT LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,551,089
+50113.3%
25,886
-38.4%
0.00%
-50.0%
Q1 2023$3,089
-77.9%
41,996
-80.0%
0.00%
-75.0%
Q4 2022$14,002
-99.9%
209,607
+26.1%
0.01%0.0%
Q3 2022$14,313,000
+102.0%
166,217
+109.3%
0.01%
+100.0%
Q2 2022$7,085,000
-51.9%
79,410
-39.4%
0.00%
-50.0%
Q1 2022$14,737,000
-27.9%
131,003
-0.9%
0.01%
-20.0%
Q4 2021$20,426,000
+63.4%
132,244
+47.3%
0.01%
+25.0%
Q3 2021$12,504,000
-50.3%
89,749
-53.2%
0.01%
-46.7%
Q2 2021$25,166,000
+16.2%
191,832
+35.0%
0.02%0.0%
Q1 2021$21,655,000
+1610.5%
142,047
+1016.2%
0.02%
+1400.0%
Q4 2020$1,266,000
-57.2%
12,726
-59.0%
0.00%
-75.0%
Q3 2020$2,955,000
-61.6%
31,002
-55.0%
0.00%
-63.6%
Q2 2020$7,699,000
-22.3%
68,830
-49.5%
0.01%
-50.0%
Q1 2020$9,907,000
+339.5%
136,233
+530.2%
0.02%
+633.3%
Q4 2019$2,254,000
+20.6%
21,616
+15.1%
0.00%0.0%
Q3 2019$1,869,000
-22.5%
18,786
-11.1%
0.00%
-25.0%
Q2 2019$2,411,000
+135.9%
21,125
+159.9%
0.00%
+100.0%
Q1 2019$1,022,000
-98.6%
8,128
-98.5%
0.00%
-98.3%
Q4 2018$74,222,000
+181.2%
546,957
+468.8%
0.12%
+262.5%
Q3 2018$26,397,000
+185.7%
96,166
+115.6%
0.03%
+166.7%
Q2 2018$9,240,000
+1853.5%
44,600
+1190.5%
0.01%
+1100.0%
Q4 2017$473,000
-49.0%
3,456
-54.8%
0.00%
-50.0%
Q2 2017$928,000
+305.2%
7,643
+239.4%
0.00%
Q4 2016$229,000
-30.2%
2,252
-41.2%
0.00%
-100.0%
Q3 2015$328,000
-85.0%
3,829
-82.3%
0.00%
-75.0%
Q2 2015$2,183,000
-46.1%
21,632
-58.8%
0.00%
-50.0%
Q1 2015$4,053,000
-50.3%
52,555
-65.7%
0.01%
-52.9%
Q4 2014$8,149,000
-17.7%
153,157
-27.3%
0.02%
-32.0%
Q3 2014$9,905,000
+186.0%
210,783
+279.2%
0.02%
+150.0%
Q2 2014$3,463,000
+37.5%
55,589
+48.4%
0.01%
+42.9%
Q1 2014$2,519,000
-22.6%
37,449
-50.2%
0.01%
-30.0%
Q3 2013$3,256,000
+1092.7%
75,233
+931.3%
0.01%
+900.0%
Q2 2013$273,0007,2950.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders